Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis
npj Regenerative Medicine · 13.01.2024 · 9 (1)
DOI: 10.1038/s41536-024-00348-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift npj Regenerative Medicine, online erschienen am 13.01.2024. Verfasst von Cheng Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chan…. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China (National Science Foundation of China), Basic Research Program of Jiangsu Province, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Renal interstitial fibrosis (RIF) is a fundamental pathological feature of chronic kidney disease (CKD). However, toxicity and poor renal enrichment of fibrosis inhibitors limit their further applications. In this study, a platform for CKD therapy is developed using superparamagnetic iron oxide nanoparticles (SPION) decorated mesenchymal stem cells derived extracellular vesicles with carboxyl terminus of Hsc70-interacting protein (CHIP) high expression (SPION-EVs) to achieve higher renal-targeting antifibrotic therapeutic effect. SPION-EVs selectively accumulate at the injury renal sites under an external magnetic field. Moreover, SPION-EVs deliver CHIP to induce Smad2/3 degradation in renal tubular cells which alleviates Smad2/3 activation-mediated fibrosis-like changes and collagen deposition. The extracellular vesicle engineering technology provides a potential nanoplatform for RIF therapy through CHIP-mediated Smad2/3 degradation.
Autor:innen und Institutionen
- Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chang Zhou, Jiangsu, China.
- Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Department of laboratory Medicine, Jiangsu University, Zhenjiang, China.
- Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chang Zhou, Jiangsu, China. jianhuajin88@sina.com.
- Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu University, Wujin Hospital Affiliated with Jiangsu University, Chang Zhou, Jiangsu, China. lstmmmlst@163.com.
- Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Department of laboratory Medicine, Jiangsu University, Zhenjiang, China. lstmmmlst@163.com.
Förderung
- National Natural Science Foundation of China (National Science Foundation of China)
- Basic Research Program of Jiangsu Province
- China Postdoctoral Science Foundation
Zitieren
APA
Ji, C., Zhang, J., Shi, L., Shi, H., Xu, W., Jin, J., & Qian, H. (2024). Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. npj Regenerative Medicine, 9(1). https://doi.org/10.1038/s41536-024-00348-0
Vancouver
Ji C, Zhang J, Shi L, Shi H, Xu W, Jin J, et al. Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. npj Regenerative Medicine. 2024;9(1). doi:10.1038/s41536-024-00348-0
BibTeX
@article{Ji2024,
author = {Ji, Cheng and Zhang, Jiahui and Shi, Linru and Shi, Hui and Xu, Wenrong and Jin, Jianhua and Qian, Hui},
title = {Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis},
journal = {npj Regenerative Medicine},
year = {2024},
volume = {9},
number = {1},
doi = {10.1038/s41536-024-00348-0}
}
EUVIMED